International consensus panel on the treatment of primary breast cancer
Open Access
- 31 October 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (11) , 1754-1759
- https://doi.org/10.1016/0959-8049(95)00479-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast CarcinomaNew England Journal of Medicine, 1994
- Late cardiac effects of adjuvant therapy: Too soon to tell?Annals of Oncology, 1994
- Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast CancerNew England Journal of Medicine, 1993
- Adjuvant therapy of primary breast cancerAnnals of Oncology, 1992
- Axillary dissection of level I and II lymph nodes is important in breast cancer classificationEuropean Journal Of Cancer, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.Journal of Clinical Oncology, 1990
- Late effects of adjuvant oophorectomy and chemotherapy upon premenopausal breast cancer patientsAnnals of Oncology, 1990
- Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.Journal of Clinical Oncology, 1986